In conclusion, all of the results showed in this paper strongly suggested the important role of miR-122 in reversing the doxorubicin-resistance in hepatocellular carcinoma cells by regulating the tumor metabolism through the miR-122-PKM2 pathway. Here, PKM is linked to hepatocellular carcinoma.